MIM
HIMS icon

Macroview Investment Management’s Hims & Hers Health HIMS Stock Holding History

Macroview Investment Management’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-504
Closed -$9.28K – 278
2024
Q3 		$9.28K Buy
+504
New +$9.02K 0.01% 247
2024
Q2 		– Sell
-469
Closed -$7.26K – 640
2024
Q1 		$7.26K Buy
+469
New +$5.29K 0.01% 347
2023
Q4 		– Sell
-511
Closed -$3.21K – 725
2023
Q3 		$3.21K Sell
511
-722
-59% -$5.37K ﹤0.01% 507
2023
Q2 		$11.6K Buy
+1,233
New +$12.2K 0.02% 231

Other funds holding HIMS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macroview Investment Management's HIMS Position: Q4 2024 in Review

Macroview Investment Management sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 504 shares — an estimated $9.28K sold.

Macroview Investment Management first reported a position in HIMS in Q2 2023 and held it in 4 quarters. The position peaked at $11.6K in Q2 2023. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

  • Macroview Investment Management reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
  • Macroview Investment Management sold 504 Hims & Hers Health shares in Q4 2024, an estimated $9.28K.
  • Macroview Investment Management first reported a position in Hims & Hers Health in Q2 2023 and held it in 4 quarters.
  • Macroview Investment Management's Hims & Hers Health position peaked at $11.6K in Q2 2023.
  • 394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Macroview Investment Management's 13F filing for Q4 2024, filed 31 Jan 2025.